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Abstract
Purpose:  To  introduce  a  new  application  (ClinicCSF)  to  measure  Contrast  Sensitivity  Function
(CSF) with  tablet  devices,  and  to  compare  it  against  the  Functional  Acuity  Contrast  Test  (FACT).
Methods:  A  total  of  42  subjects  were  arranged  in  two  groups  of  21  individuals.  Different  versions
of the  ClinicCSF  (.v1  and  .v2)  were  used  to  measure  the  CSF  of  each  group  with  the  same  iPad
and the  results  were  compared  with  those  measured  with  the  FACT.  The  agreements  between
ClinicCSF  and  FACT  for  spatial  frequencies  of  3,  6,  12  and  18  cycles  per  degree  (cpd)  were
represented  by  Bland--Altman  plots.
Results:  Statistically  signiﬁcant  differences  in  CSF  of  both  groups  were  found  due  to  the  change
of the  ClinicCSF  version  (p  <  0.05)  while  no  differences  were  manifested  with  the  use  of  the  same
FACT test.  The  best  agreement  with  the  FACT  was  found  with  the  ClinicCSF.v2  with  no  signiﬁcant
differences  in  all  the  evaluated  spatial  frequencies.  However,  the  95%  conﬁdence  intervals  for
mean differences  between  ClinicCSF  and  FACT  were  lower  for  the  version  which  incorporated  a
staircase psychophysical  method  (ClinicCSF.v1),  mainly  for  spatial  frequencies  of  6,  12  and  18
cpd.
Conclusions:  The  new  ClinicCSF  application  for  iPad  retina  showed  no  signiﬁcant  differences
with FACT  test  when  the  same  contrast  sensitivity  steps  were  used.  In  addition,  it  is  shown
that the  accurateness  of  a  vision  screening  could  be  improved  with  the  use  of  an  appropriate
psychophysical  method.
© 2014  Spanish  General  Council  of  Optometry.  Published  by  Elsevier  España,  S.L.U.  All  rights
reserved.∗ Corresponding author at: Centro de Tecnologías Físicas, Universitat Politècnica de València, 46022 Valencia, Spain.
E-mail address: marodva1@upvnet.upv.es (M. Rodríguez-Vallejo).
http://dx.doi.org/10.1016/j.optom.2014.06.003
1888-4296/© 2014 Spanish General Council of Optometry. Published by Elsevier España, S.L.U. All rights reserved.
102  M.  Rodríguez-Vallejo  et  al.
PALABRAS  CLAVE
Función  de
sensibilidad  al
contraste;
Desempen˜o  visual;
Dispositivos  de
tableta;
iPad;
EFAC
Disen˜o de  una  nueva  prueba  para  medir  la  función  de  sensibilidad  al  contraste  con
iPad
Resumen
Objetivo:  Introducir  una  nueva  aplicación  (ClinicCSF)  para  medir  la  Función  de  Sensibilidad  al
Contraste (FSC)  con  dispositivos  de  tableta,  y  compararla  con  el  test  Functional  Acuity  Contrast
Test (FACT).
Métodos:  Se  distribuyeron  42  sujetos  en  dos  grupos  de  21  personas.  Se  utilizaron  diferentes
versiones  del  ClinicCSF  (.v1  y  .v2)  para  medir  la  FSC  de  cada  grupo  con  el  mismo  iPad,  com-
parándose  los  resultados  obtenidos  con  los  medidos  con  el  test  FACT.  Se  representaron  las
concordancias  entre  ClinicCSF  y  FACT  para  frecuencias  espaciales  de  3,  6,  12  y  18  ciclos  por
grado (cpg)  mediante  gráﬁcos  de  Bland--Altman.
Resultados:  Se  hallaron  diferencias  de  FSC  estadísticamente  signiﬁcativas  en  ambos  gru-
pos debido  al  cambio  de  versión  del  ClinicCSF  (p  <  0.05),  mientras  que  no  se  manifestaron
diferencias  con  el  test  FACT.  La  mejor  concordancia  con  el  FACT  se  obtuvo  con  el
ClinicCSF.v2, no  hallándose  diferencias  signiﬁcativas  en  todas  las  frecuencias  espaciales
evaluadas.  Sin  embargo,  los  intervalos  de  conﬁanza  del  95%  para  las  diferencias  medias
entre ClinicCSF  y  FACT  fueron  inferiores  para  la  versión  que  incorporó  un  método  psi-
cofísico de  escalera  (ClinicCSF.v1),  principalmente  para  frecuencias  espaciales  de  6,  12  y  18
cpg.
Conclusiones:  La  nueva  aplicación  ClinicCSF  para  el  iPad  retina  no  reﬂejó  diferencias  signi-
ﬁcativas con  el  test  FACT  al  utilizar  los  mismos  pasos  de  sensibilidad  al  contraste.  Además,  la
precisión  del  examen  visual  puede  mejorarse  con  el  uso  de  un  método  psicofísico  adecuado.
© 2014  Spanish  General  Council  of  Optometry.  Publicado  por  Elsevier  España,  S.L.U.  Todos  los
derechos reservados.
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Fntroduction
he  Contrast  Sensitivity  Function  (CSF)  has  been  generally
ccepted  as  a  better  predictor  of  visual  performance  than
igh  contrast  Visual  Acuity  (VA).  In  fact,  VA  is  usually  con-
idered  as  a  measure  of  the  clarity  of  vision,  and  it  basically
epends  on  the  ﬁnest  detail  that  an  eye  can  resolve.  On  the
ther  hand,  the  CSF  is  a  more  complete  metric  since  it  is  a
easure  of  the  threshold  contrast  needed  to  see  spatially
arying  stimuli.1 Indeed,  the  CSF  is  nowadays  considered
 routine  clinical  tool  in  optical  quality  assessment  of  the
ye2,3 and  in  eye  disease  detection  (e.g.,  cataracts,4 optic
erve  pathologies,5,6 retinitis  pigmentosa,7,8 glaucoma,9,10
tc.).
When  CSF  testing  was  initially  introduced  in  clinical
ractice  and  clinical  research,  tests  usually  consisted  of
omputer-generated  visual  images.  However,  those  devices
ere  typically  costly,  they  needed  a  calibration  and  nor-
ative  data  that  were  not  readily  available.  Consequently,
hart-based  methods  for  assessing  CSF  were  developed  in
he  early  1980s.11
In  clinical  practice,  Contrast  Sensitivity  (CS)  is  gener-
lly  measured  by  means  of  optotypes  of  different  contrast,
uch  as  Pelli-Robson  Chart12 or  by  means  of  sinusoidal  grat-
ngs  of  different  spatial  frequency.13 The  main  difference
etween  them  is  that  an  optotype  contains  a  wide  range
f  spatial  frequencies  whose  relative  weights  depend  on
he  letter  and  its  size,  while  a  sinusoidal  grating  evalu-
tes  the  response  of  the  visual  system  to  a  single  spatial
requency.14
t
y
C
GToday,  the  most  popular  commercial  tests  for  measuring
SF  by  means  of  sinusoidal  gratings  are:  Functional  Acu-
ty  Contrast  Test  (FACT),15 and  the  Vector  Vision  CSV-1000
VectorVision,  Greenville,  OH).16 These  tests  commonly  use
 patches  for  each  spatial  frequency  but  they  differ  in:
he  speciﬁc  spatial  frequencies  evaluated,  in  the  step  con-
rast  sizes  and  ranges,  and  in  the  psychophysical  method  to
chieve  the  threshold.
Since  tablets  appeared,  new  applications  (apps)  have
een  proposed  in  the  ophthalmology  and  optometry
ractice.17,18 The  great  advantages  of  these  devices  are  that
hey  offer  the  possibility  to  standardize  vision  screenings,
nd  since  there  are  many  common  models  which  share  char-
cteristics  such  as  screen  chromaticity  and  resolution,  the
hromatic  properties  of  such  devices  might  be  assumed  to
e  nearly  the  same.  The  aim  of  this  study  is  to  introduce
 new  App,  called  ClinicCSF19 to  measure  CSF  with  tablet
evices  and  to  compare  it  with  other  commercial  device:  the
ptec  Visual  Function  Analyzer  (Stereooptical,  Chicago)20
hat  contains  the  FACT.
ethods
ubjects  and  instruments
orty-two  subjects  divided  into  two  groups  participated  in
his  study.  Subjects  from  the  Group  1  (mean  age,  33  ±  12
ears)  were  examined  by  a  trained  optometrist  with  the
linicCSF.v1  in  an  optometry  center.  Subjects  from  the
roup  2,  members  of  the  staff  and  students  from  the
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Figure  1  Appearance  of  the  ClinicCSF  app  during  the  testing
process.  A  single  sinusoidal  grating  is  displayed  with  a  blurred
Spatial frequency (cpd)
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Figure  2  CS  values  in  log  units  for  each  one  of  the  patches
in both  versions  of  the  ClinicCSF.  The  contrast  sensitivity  step
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Gcircular  edge  that  smoothes  the  grating  into  an  achromatic
background.
University  of  Valencia  (mean  age,  37  ±  11  years),  were
measured  with  the  ClinicCSF.v2  by  a  different  practitioner.
The  iPad  with  Retina  display  (2048-by-1536-pixel  resolution
at  264  ppi)  and  the  FACT  used  in  both  screenings  were  the
same.  Monocular  VA  was  measured  in  both  groups  with
the  ETDRS  procedure  included  in  the  Optec,  previously  to
monocular  measurement  with  ClinicCSF  and  FACT. Exclu-
sion  criteria  were  strabismus  and  any  cause  of  monocular
reduced  visual  acuity  with  habitual  correction  (worse
than  0.3  logMAR).  Informed  consent  was  obtained  for  each
subject  and  the  research  was  conducted  in  accordance  with
the  principles  laid  down  in  the  Declaration  of  Helsinki.
App  description
ClinicsCSF  is  an  app  developed  by  pure  mobile  ActionScript
3.0  code  that  can  be  compiled  for  iPad  or  Android  devices.
The  app  loads  9  patches  of  sinusoidal  gratings  for  spatial  fre-
quencies  of  3,6,12  and  18  cpd  created  with  MATLAB  software
(The  MathWorks,  Natick,  MA)  and  the  COLORLAB21 library.
This  library  was  used  to  calibrate  the  iPad  screen  by  comput-
ing  the  function  that  links  the  digital  values  with  the  XYZ-CIE
tristimulus  values  and  to  compute  the  sinusoidal  gratings  as
follows:  First,  for  each  RGB  channel  of  the  iPad  (primary  col-
ors)  and  for  an  equal  combination  of  the  three  (gray  scale),
ten  equally  spaced  colors  were  generated  and  measured
with  a  Spyder4Elite  colorimeter  obtaining  the  calibration
function.  Second,  the  calibration  data  were  loaded  and  the
digital  values  of  the  gratings  were  computed  from  the  tris-
timulus  values  with  the  COLORLAB  library.  Finally,  the  true
color  patches  were  exported  to  JPG  format  to  be  compiled
into  the  ClinicCSF  app.  To  minimize  edge  effects,  stimuli
were  generated  with  blurred  edges  by  means  of  a  half-
Gaussian  ramp  that  fades  the  stimuli  with  an  achromatic22
background  of  86  cd/m2 mean  luminance  (CIE  xy  coordi-
nates:  0.33,  0.33).
The  app  was  designed  to  be  presented  at  a  distance
of  2  m  for  which  a  stimulus  of  4  cm  subtended  1◦ (Fig.  1),
therefore  the  experimenter  holds  the  iPad  at  this  distance
a
i
w
aizes for  the  ClinicCSF.v2  and  the  FACT  were  the  same  (black
ots).
rom  the  subject  and  presses  the  button  that  corresponds
o  the  subject’s  response.  Two  different  versions,  called
‘ClinicCSF.v1’’  and  ‘‘ClinicCSF.v2’’,  were  developed.  In
oth  versions,  the  stimuli  were  presented  randomly  in  dif-
erent  orientations:  vertical,  tilted  15◦ to  the  right  or  tilted
5◦ to  the  left.  The  main  differences  between  ClinicCSF.v1
nd  .v2  were  the  psychophysical  method  used  to  achieve
he  CSF  threshold  and  the  step  sizes  between  each  one  of
he  CS  levels.  The  ClinicCSF.v1  was  programmed  with  the
ame  contrast  sensitivity  values  that  the  CSV1000  and  the
linicCSF.v2  with  the  FACT  values  in  order  to  allow  a  better
omparison  with  previously  reported  results  (Fig.  2).
With  the  ClinicCSF.v1, a  simple-up  down  staircase23 psy-
hophysical  method  was  used  starting  in  the  ﬁfth  patch  level
or  each  spatial  frequency.  In  this  method,  CS  goes  one  level
p  (e.g.  from  level  5  to  6)  after  each  right  answer  until  the
bserver  fails.  Then,  CS  goes  down  until  the  observer  gets
ight  again.  The  CS  threshold  was  determined  by  averaging
he  sensitivities  at  the  turnaround  points  (i.e.  the  CS  at  the
evels  where  direction  changed)  in  the  adaptive  track  for  a
otal  of  ﬁve  reversals.
The  psychophysical  method  adopted  for  ClinicCSF.v2
onsisted  of  three  steps:  (1)  starting  at  the  ﬁrst  level,  it
oes  one  level  up  after  each  right  answer  until  the  observer
ails;  (2)  the  same  procedure  than  previous  step  but  starting
wo  levels  below  the  level  on  which  the  answer  was  wrong
n  step  1;  (3)  the  exam  ends  after  two  successive  wrong
esponses  as  the  FACT  procedure  being  the  CS  threshold  the
orresponding  to  the  latest  correct  answer.
xperimental  procedures
he  same  procedure  was  followed  for  both  groups  of  sub-
ects  who  wore  their  habitual  correction.  Subjects  from
roup  1  and  Group  2  were  evaluated  with  the  ClinicCSF.v1
nd  .v2  respectively,  and  with  the  FACT. The  ambient  light-
ng  conditions  were  around  15  lux  during  all  measurements
ith  ClinicCSF  and  FACT  in  both  groups.  Pupil  size  and
ccommodation  were  not  controlled  artiﬁcially  because  this
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Table  1  Comparisons  of  medians  (ranges)  between  ClinicCSF.v1  vs  FACT  from  Group  1  and  ClinicCSF.v2  and  FACT  from  Group  2.
Spatial  frequency
(cpd)
Subjects  Group  1  Subjects  Group  2
ClinicCSF.v1  FACT  Wilcoxon
test
ClinicCSF.v2  FACT  Wilcoxon
test
Median (range)  Median  (range)  Median  (range)  Median  (range)
3  2.03  (1.47--2.08)  2.06  (1.46--2.20)  p  =  0.193  2.06  (1.18--2.06)  2.06  (1.60--2.20)  p  =  0.108
6 1.99  (1.39--2.29) 1.81  (1.20--2.26) p  <  0.001  1.95  (1.20--2.11)  1.88  (1.08--2.11)  p  =  0.636
12 1.65  (1.18--1.94) 1.48  (0.90--2.08) p  <  0.001 1.48  (0.90--2.08)  1.55  (0.90--1.93)  p  =  0.207
p  <  0
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F18 1.20  (0.81--1.56) 1.08  (0.60--1.66)
tudy  attempted  to  gain  an  understanding  of  the  nature  of
SF  in  the  natural  state  of  the  eyes.  The  FACT  offers  four
ossible  conﬁgurations  in  the  measurement  of  the  CSF,  so
he  ‘‘day  condition  without  glare’’  was  chosen  in  this  exper-
ment.  Both  the  ClinicCSF  and  the  FACT  were  performed  in
he  same  session.  The  time  involved  in  the  CSF  measurement
ith  each  test  was  approximately  2  min.
tatistical  analysis
oth  eyes  were  considered  in  the  statistical  analysis  due
o  the  low  correlation  that  was  obtained  between  their  CS
alues  using  the  kappa  statistic  (  <  0.20).24 Differences  in
ge,  VA,  and  CS  between  groups  were  evaluated  using  the
ann--Whitney  test,  and  comparison  between  tests  in  the
ame  group  was  computed  with  Wilcoxon  test.  This  anal-
sis  was  based  on  a  non-normal  distribution  of  the  data.
n  the  other  hand,  as  the  difference  of  scores  between
ests  was  normally  distributed,  Bland--Altman  procedure25
as  used  to  assess  the  agreement  between  each  one  of  the
linicCSF  versions  and  the  FACT. The  data  were  managed
sing  SPSS  software  version  20  (SPSS  Inc.,  Chicago,  IL,  USA),
nd  p  <  0.05  was  considered  to  indicate  signiﬁcance.
esults
o  statistical  differences  were  found  in  age  between  both
roups  of  subjects  (p  =  0.064)  and  median  monocular  visual
cuities  were  0  logMAR  (range,  −0.2  to  0.3)  in  the  Group  1
nd  0  logMAR  (range,  −0.2  to  0.2)  in  the  Group  2  (p  =  0.570).
Median  CS  and  range  scores  obtained  at  each  spatial
requency  are  summarized  for  both  groups  in  Table  1  and
o
c
l
Table  2  Comparisons  of  medians  (ranges)  between  groups  using  t
application.
Spatial  frequency
(cpd)
FACT  
Group  1  Group  2  Mann--W
Median (range)  Median  (range)  
3  2.06  (1.46--2.20)  2.06  (1.60--2.20)  p  =  0.789
6 1.81  (1.20--2.26)  1.88  (1.08--2.11)  p  =  0.930
12 1.48  (0.90--2.08)  1.55  (0.90--1.93)  p  =  0.881
18 1.08  (0.60--1.66)  1.08  (0.60--1.52)  p  =  0.614.001 1.08  (0.60--1.66) 1.08  (0.60--1.52) p  =  0.959
raphically  represented  by  means  of  box  plot  whiskers  in
ig.  3. The  CSF  median  values  were  generally  higher  for  the
linicCSF.v1  than  for  the  FACT  test  in  Group  1  (Fig.  3A);  the
ifferences  were  statistically  signiﬁcant  (p  <  0.001)  for  all
requencies  except  for  3  cpd.  However,  the  ClinicCSF.v2  gave
imilar  scores  than  the  FACT  for  all  the  evaluated  spatial
requencies  in  subjects  from  Group  2  (p  >  0.05)  (Fig.  3B).
As  can  be  seen  in  Table  2, both  groups  gave  similar
ontrast  sensitivities  when  the  same  FACT  test  was  used
o  perform  the  exam  (p  >  0.05). Even  though  both  groups
eported  similar  CSs  with  the  FACT  test  (Fig.  4A),  there
xisted  signiﬁcant  differences  between  groups  when  they
ere  measured  with  different  versions  of  the  ClinicCSF  for
patial  frequencies  of  6  and  18  cpd  (p  <  0.05) (Fig.  4B).
In  Fig.  5,  Bland--Altman  plots  are  represented  by
eans  of  the  difference  between  the  two  methods  [Clin-
cCSF.v1  −  FACT] against  the  mean  [(ClinicCSF.v1  +  FACT)/2].
he  same  representation  was  also  done  for  the  ClinicCSF.v2
nd  the  FACT  in  Fig.  6  by  a  direct  comparison  of  each  one
f  the  spatial  frequencies.  It  can  be  seen  that  the  Clin-
cCSF.v1  overestimated  the  CS  with  respect  to  the  FACT,
nd  this  overestimation  was  not  found  with  the  ClinicCSF.v2
continuous  lines  in  Figs.  5  and  6).  It  should  also  be  noted
hat  although  we  found  less  differences  between  the  Clin-
cCSF.v2  vs.  FACT  than  between  the  ClinicCSF.v1  vs.  FACT,
arrower  agreement  limits  were  obtained  with  the  stair-
ase  psychophysical  method  of  the  ClinicCSF.v1; mainly  for
patial  frequencies  of  6,  12,  and  18  cpd  (dashed  lines  in
igs.  5  and  6).Correlations  between  differences  versus  mean  scores
btained  with  tests  were  analyzed  by  the  Pearson  coefﬁ-
ient  (r)  and  represented  in  the  Bland--Altman  plots  by  linear
east  squares  ﬁtting  in  case  of  being  statistically  signiﬁcant
he  same  FACT  test  and  two  different  versions  of  the  ClinicCSF
ClinicCSF
hitney  Group  1  (v1)  Group  2  (v2)  Mann--Whitney
Median  (range)  Median  (range)
 2.03  (1.47--2.08)  2.06  (1.18--2.06)  p  =  0.051
 1.99  (1.39--2.29)  1.95  (1.20--2.11)  p  =  0.009
 1.65  (1.18--1.94)  1.48  (0.90--2.08)  p  =  0.090
 1.20  (0.81--1.56)  1.08  (0.60--1.66)  p  =  0.021
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Figure  3  Box  plot  diagrams  showing  median  contrast  sensitiv-
ity values.  (A)  ClinicCSF.v1  and  Functional  Acuity  Contrast  Test
(FACT) measured  in  Group  1  of  subjects  (B)  ClinicCSF.v2  and
Group 1 (FACT)
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Figure  4  Box  plot  diagrams  showing  median  contrast  sensi-
tivity values.  (A)  Group  1  and  Group  2  of  subjects  measured
with the  Functional  Acuity  Contrast  Test  (FACT).  (B)  Group  1
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regard  to  the  comparison  of  the  same  test  with  differentFACT measured  in  Group  2  of  subjects.
(p  <  0.05).  Therefore  as  can  be  seen  in  Fig.  5  for  the  com-
parison  between  ClinicCSF.v1  and  FACT, the  regression  lines
show  positive  correlations  with  the  increment  of  mean  CS
for  3,  12  and  18  cpd  (r  =  0.37,  0.56  and  0.34,  respectively).
On  the  other  hand,  the  correlation  was  signiﬁcant  only  for
6  cpd  (r  =  0.44)  in  the  comparison  between  ClinicCSF.v2  and
FACT  (Fig.  6).
Discussion
The  aim  of  this  study  was  to  present  a  new  iPad  app  to
measure  CSF.  Two  versions  (ClinicCSF.v1  and  .v2)  have  been
proposed  and  tested  in  comparison  with  other  commercial
test  (FACT).  Although  two  different  groups  of  subjects  were
used  in  the  evaluation  of  each  one  of  the  ClinicCSF  versions,
no  statistical  differences  in  visual  acuity  and  age  were  found
between  both  groups.  Special  attention  was  paid  on  age  of
participants  considering  that  CSF  could  be  inﬂuenced  by  this
variable26.  In  fact,  some  commercially  available  tests,  such
as  the  CSV1000,  have  different  normative  ranks  depending
on  age  of  the  subjects.27
c
o
snd Group  2  of  subjects  measured  with  the  ClinicCSF.v1  and
linicCSF.v2, respectively.
We  found  signiﬁcant  differences  between  ClinicCSF.v1
nd  FACT  for  all  spatial  frequencies  except  for  3  cpd
Table  1).  This  lack  of  agreement  can  be  attributed  ﬁrstly
o  the  fact  that  each  test  measures  different  CS  levels
Fig.  2)  and  secondly  to  the  different  psychophysical  method
mployed  in  each  version.  Other  comparative  studies  also
ound  discrepancies  due  to  the  similar  reasons.  Franco
t  al.13 compared  the  VCTS-6500  and  the  CSV-1000  and
ound  mean  differences  of  0.30,  0.20,  0.08  and  0.18  for
patial  frequencies  of  3,  6,  12  and  18  cpd,  respectively,
he  differences  being  statistically  signiﬁcant  for  all  spatial
requencies.  Such  differences  are  even  higher  than  those
btained  in  the  present  study  except  for  12  cpd  (Fig.  5).
s  expected,  the  differences  between  the  ClinicCSF.v2  and
he  FACT  were  very  much  lower  due  to  both  tests  having
he  same  CS  levels  and  use  the  same  thresholding  technique
Fig.  6),  unlike  the  ClinicCSF.v1  and  FACT  (Fig.  5).
Other  researchers  have  sounded  a  note  of  caution  withonﬁgurations.  For  instance,  FACT  differs  from  the  previ-
us  Vistech  version  in  several  characteristics:  using  smaller
tep  sizes,  a  3  alternative  forced  choice,  ‘‘blurred’’  grating
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Figure  5  Bland--Altman  plots.  CS  difference  between  methods  versus  mean  of  CS  scores  measured  with  FACT  and  ClinicCSF.v1  for
spatial frequencies  of  3  cpd  (top-left),  6  cpd  (top-right),  12  cpd  (bottom-left),  and  18  cpd  (bottom-right).  The  solid  lines  represent
the mean  difference  between  the  two  instruments  and  the  dashed  lines  correspond  to  the  95%  conﬁdence  interval  (mean  ±  1.96SD).  A
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Cinear ﬁt  was  done  for  statistically  signiﬁcant  correlations  (p  <  0.
2 cpd  (r  =  0.56),  and  18  cpd  (r  =  0.34).
atch  edges  with  the  gratings  smoothed,  and  a  larger  patch
ize  to  increase  number  of  cycles  at  low  spatial  frequencies.
esudovs  et  al.28 attributed  dissimilar  results  between  Vis-
ech  and  FACT  to  the  fact  that  this  new  version  uses  smaller
tep  sizes  with  the  same  number  of  steps,  and  thus  ranges
f  measurement  are  also  smaller.  As  a  consequence,  they
eported  a  ceiling  effect  in  post-LASIK  patients  and  a  ﬂoor
ffect  in  cataract  patients.  Furthermore,  Hitchcock  et  al.29
howed  that  not  only  step  sizes  could  have  inﬂuence  on  the
S  since  they  found  that  although  contrast  levels  were  the
ame,  results  could  be  different  depending  on  the  way  tests
ere  presented.
Positive  correlations  between  mean  differences  and  the
verage  of  CS  were  found  with  the  ClinicCSF.v1  for  three
patial  frequencies  (Fig.  5).  These  correlations  represent
hat  the  CS  with  ClinicCSF.v1  was  higher  than  FACT  mainly
n  subjects  with  poorer  CS.  Signiﬁcance  of  this  correlation
isappeared  with  the  ClinicCSF.v2  and  curiously  the  only
igniﬁcant  correlation  between  ClinicCSF.v2  and  FACT  was
iscovered  at  6  cpd  (Fig.  6),  spatial  frequency  that  was  not
igniﬁcant  with  ClinicCSF.v1. We  consider  that  these  cor-
elations  might  mainly  be  due  to  step  sizes  with  the  same
d
o
s
tnd  the  Pearson  coefﬁcients  (r)  are  reported  for  3  cpd  (r  =  0.37),
umber  of  steps  as  was  mentioned  before  when  we  discussed
he  conclusions  of  Pesudovs  et  al.28 This  would  appear  to
ndicate  that  ceiling  and  ﬂoor  effects  might  also  appear  for
he  comparison  between  ClinicCSF.v1  and  FACT  in  cataract
nd  refractive  surgery  patients.
We  also  found  that  mean  differences  conﬁdence  inter-
als  were  highly  inﬂuenced  by  the  psychophysical  method
sed  to  achieve  the  CS  threshold.  Conﬁdence  intervals  of
he  Bland--Altman  plots  for  differences  between  ClinicCSF.v1
nd  FACT  were  narrowed  by  using  a  staircase  method
Fig.  5).  This  fact  underlines  the  importance  of  including  a
sychophysical  method  in  iPad  based  screening  tests  instead
f  using  it  simply  as  an  illuminated  screen.30,31
The  biggest  differences  in  the  CSFs  between  groups  were
ound  when  we  changed  some  properties  of  the  test  design
Table  2).  This  demonstrates  just  how  important  is  it  to  use
he  same  test  in  the  comparison  between  groups  of  subjects.
onsequently,  clinical  results  in  studies  which  implement
ifferent  CS  tests  might  also  differ  due  to  the  conﬁguration
f  tests  used.  In  fact,  the  discrepancies  in  the  comparison  of
everal  CS  tests  have  been  widely  studied,  mainly  in  order
o  obtain  normative  data  for  contrast  sensitivity  functions.32
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Figure  6  Bland--Altman  plots.  CS  difference  between  methods  versus  mean  of  CS  scores  measured  with  FACT  and  ClinicCSF.v2  for
spatial frequencies  of  3  cpd  (top-left),  6  cpd  (top-right),  12  cpd  (bottom-left),  and  18  cpd  (bottom-right).  The  solid  lines  represent
the mean  difference  between  the  two  instruments  and  the  dashed  lines  correspond  to  the  95%  conﬁdence  interval  (mean  ±  1.96SD).  A
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Alinear ﬁt  was  done  for  statistically  signiﬁcant  correlations  (p  <  0.
One  limitation  of  this  study  is  that  two  different  groups
of  subjects  were  used  to  compare  each  one  of  the  Clin-
icCSF  versions  with  the  FACT. The  reason  is  that  ClinicCSF.v1
was  ﬁrst  designed  and  evaluated  clinically  with  one  group  of
subjects.  Lately  ClinicCSF.v2  was  developed  as  an  improved
version  of  ClinicCSF.v1  and  it  was  not  possible  to  measure
the  same  group  of  subjects.  A  better  statistical  analysis  of
variance  could  have  been  done  if  we  had  measured  the  CSF
with  the  three  tests  in  the  same  group  of  subjects.  Other
limitation  of  our  current  proposal  is  related  to  the  maxi-
mum  brightness  conﬁguration  of  the  iPad  that  might  produce
a  glare  effect  in  some  patients,  and  a  possible  post-image
after  each  answer.  This  issue  should  be  considered  in  future
versions  of  the  app.
Our  work  led  us  to  conclude  that  ClinicCSF  app,  designed
for  a  given  tablet  device,  can  give  similar  results  than  FACT
in  CSF  measurement  in  a  normal  population.  Further  exper-
iments  using  the  ClinicCSF  app  in  different  versions  of  the
same  device  are  required  in  order  to  extrapolate  our  results.
The  ﬁndings  might  not  be  generalized  to  all  the  iPad  screens
because  the  uniformity  of  colorimetric  and  photometric
properties  among  all  iPads  has  not  yet  been  proven.  We
W
E
end  the  Pearson  coefﬁcients  (r)  are  reported  for  6  cpd  (r  =  0.44).
hink  that  our  new  test  could  be  useful  to  popularize  the
SF  measurement  in  centers  that  do  not  usually  perform
t,  due  to  the  high  cost  of  current  commercial  equipment.
urther  experimental  investigations  are  also  needed  to  esti-
ate  normative  ranges  and  ROC  curves.
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